Lipid oligonucleotides as a new strategy for tackling the antibiotic resistance

por Kauss, Tina, Arpin, Corinne, Bientz, Léa, Vinh Nguyen, Phouc, Vialet, Brune, Benizri, Sebastien, Barthélémy, Philippe
Publicado 2020

Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery

por Benizri, Sebastien, Ferey, Ludivine, Alies, Bruno, Mebarek, Naila, Vacher, Gaelle, Appavoo, Ananda, Staedel, Cathy, Gaudin, Karen, Barthélémy, Philippe
Publicado 2018

FXYD2 antisense oligonucleotide provides an efficient approach for long-lasting relief of chronic peripheral pain

por Derre, Alexandre, Soler, Noelian, Billoux, Valentine, Benizri, Sebastien, Vialet, Brune, Rivat, Cyril, Barthélémy, Philippe, Carroll, Patrick, Pattyn, Alexandre, Venteo, Stephanie
Publicado 2023

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment

por Nguyen, Dang Tan, Le, Thi Khanh, Paris, Clément, Cherif, Chaïma, Audebert, Stéphane, Oluchi Udu-Ituma, Sandra, Benizri, Sébastien, Barthélémy, Philippe, Bertucci, François, Taïeb, David, Rocchi, Palma
Publicado 2021

Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer

por Ziouziou, Hajer, Paris, Clément, Benizri, Sébastien, Le, Thi Khanh, Andrieu, Claudia, Nguyen, Dang Tan, Appavoo, Ananda, Taïeb, David, Brunel, Frédéric, Oueslati, Ridha, Siri, Olivier, Camplo, Michel, Barthélémy, Philippe, Rocchi, Palma
Publicado 2021